Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Dunning

Showing results (411-420 of 536) with videos related to

Pageof 54
Sort By:
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
Scientific Reports|September 8, 2016
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)Hatef Darabi, Jonathan Beesley, Arnaud Droit, et al.
Human Molecular Genetics|July 13, 2016
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionAsaf Wyszynski, Chi-Chen Hong, Kristin Lam, et al.
Genome Medicine|May 18, 2022
Breast cancer risks associated with missense variants in breast cancer susceptibility genesLeila Dorling, Sara Carvalho, Jamie Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
Cancer Causes & Control : CCC|April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestryZhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Pageof 54

Showing results (411-420 of 536) with videos related to

Sort By:
Pageof 54
Plos One|August 25, 2016
Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility LocusHisani N Horne, Charles C Chung, Han Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 11, 2015
Fine-scale mapping of the 4q24 locus identifies two independent loci associated with breast cancer riskXingyi Guo, Jirong Long, Chenjie Zeng, et al.
Scientific Reports|September 8, 2016
Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)Hatef Darabi, Jonathan Beesley, Arnaud Droit, et al.
Human Molecular Genetics|July 13, 2016
An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expressionAsaf Wyszynski, Chi-Chen Hong, Kristin Lam, et al.
Genome Medicine|May 18, 2022
Breast cancer risks associated with missense variants in breast cancer susceptibility genesLeila Dorling, Sara Carvalho, Jamie Allen, et al.
Medrxiv : the Preprint Server for Health Sciences|September 16, 2024
Analysis of more than 400,000 women provides case-control evidence for <i>BRCA1</i> and <i>BRCA2</i> variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Nature Communications|May 24, 2025
Analysis of more than 400,000 women provides case-control evidence for BRCA1 and BRCA2 variant classificationMaria Zanti, Denise G O'Mahony, Michael T Parsons, et al.
Research Square|February 24, 2023
Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survivalAnna Morra, Maartje A C Schreurs, Irene L Andrulis, et al.
Human Mutation|February 21, 2018
The BRCA2 c.68-7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicityMara Colombo, Irene Lòpez-Perolio, Huong D Meeks, et al.
Cancer Causes & Control : CCC|April 8, 2016
Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestryZhiguo Zhao, Wanqing Wen, Kyriaki Michailidou, et al.
Pageof 54